Rankings
▼
Calendar
CMPX Q1 2025 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CMPX
Compass Therapeutics, Inc.
$781M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$18M
Net Income
-$17M
EPS (Diluted)
$-0.12
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$131M
Total Liabilities
$21M
Stockholders' Equity
$110M
Cash & Equivalents
$41M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$18M
-$13M
-40.7%
Net Income
-$17M
-$11M
-54.2%
← FY 2025
All Quarters
Q2 2025 →